Judy

The global testicular implants market is being estimated at about $71 million in 2026 in the report you referenced, reflecting steady demand in reconstructive urology and related specialty care. For healthcare procurement teams and marketplace operators, this matters because it affects sourcing, supplier vetting, lifecycle planning, and trade flows for silicone and saline-filled prostheses. HHG […]

The EAU 2026 testicular cancer guidance reinforces standardized counseling around testicular prosthesis placement after orchidectomy, with stronger emphasis on timing, shared decision-making, and documentation. For healthcare procurement teams, that matters because prosthesis availability, sterile handling, supplier vetting, and post-surgical supply coordination now sit closer to the center of care pathways. In a B2B medical equipment

NHS Supply Chain’s “Surgical Implants for Men’s and Women’s Health” framework is a 24-month procurement route that starts on 1 April 2026 and runs to 31 March 2028, with an option to extend for another 24 months. It gives NHS trusts and eligible UK healthcare buyers a structured way to source vetted suppliers, either through

The urology devices market is expanding as outpatient procedures, consumables, and clinic-level purchasing needs grow, creating more demand for flexible sourcing and resale channels. For healthcare buyers and sellers, a B2B medical equipment marketplace can improve access to new, used, pre-owned, and refurbished devices while adding buyer protection, vetted suppliers, and transaction security. What Are

The 2026 Testicular Cancer Conference agenda reinforces a broader healthcare trend: survivorship now includes physical, emotional, and prosthetic restoration, not just acute treatment. For B2B medical equipment buyers and sellers, that matters because clinic procurement increasingly has to account for patient-centered recovery services, privacy-ready equipment handling, and support networks around prostheses, imaging, and follow-up care.

Tariffs and supply‑chain disruptions are increasing baseline manufacturing and import costs for cooling components, electronic sensors, and assemblies used in professional body‑sculpting and other aesthetic devices. As a result, certified refurbished medical equipment offers clinics, hospitals, and dealers a more cost‑effective, compliant alternative to brand‑new technology, while still meeting clinical and regulatory expectations. This shift

CoolSculpting Elite is the newer dual-applicator evolution of CoolSculpting, while the original Legacy platform remains a widely understood cryolipolysis system for clinics buying used or pre-owned equipment. For B2B buyers, the real question is not clinical hype but operational fit: throughput, refurbishment status, serviceability, documentation, and resale value. In a marketplace like HHG GROUP, both

Cryolipolysis demand is rising in 2026 because clinics want non-invasive body contouring equipment that can generate revenue without major downtime, while buyers increasingly prefer used medical equipment, refurbished devices, and platform-mediated transactions that reduce acquisition risk. The market report projects the global cryolipolysis market at $1.89 billion in 2026, up from $1.67 billion in 2025,

Layered, long‑term multimodal treatment plans are now the patient expectation: clinics should treat device strategy, procurement, and service partnerships as integral to care delivery, selecting foundational fat‑reduction systems (e.g., cryolipolysis) alongside complementary toning, tightening, and energy-based devices to offer bundled care while managing regulatory, lifecycle, and procurement risks. For Sale ZELTIQ AESTHETICS COOLSCULPTING machine Laser

Allergan Aesthetics’ fourth annual CoolMonth campaign is likely to increase patient inquiries and appointment volume for CoolSculpting-focused practices, which can translate into stronger demand for ZELTIQ/CoolSculpting systems and related service capacity in the secondary equipment market. For HHG GROUP users, that means a timely opportunity to evaluate used medical equipment, refurbished devices, and trade-in options